279 related articles for article (PubMed ID: 16314949)
1. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
Hall WA; Doolittle ND; Daman M; Bruns PK; Muldoon L; Fortin D; Neuwelt EA
J Neurooncol; 2006 May; 77(3):279-84. PubMed ID: 16314949
[TBL] [Abstract][Full Text] [Related]
2. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Jahnke K; Kraemer DF; Knight KR; Fortin D; Bell S; Doolittle ND; Muldoon LL; Neuwelt EA
Cancer; 2008 Feb; 112(3):581-8. PubMed ID: 18072268
[TBL] [Abstract][Full Text] [Related]
4. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
[TBL] [Abstract][Full Text] [Related]
5. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
Fortin D; Gendron C; Boudrias M; Garant MP
Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
[TBL] [Abstract][Full Text] [Related]
6. Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
Tyson RM; Siegal T; Doolittle ND; Lacy C; Kraemer DF; Neutwelt EA
Leuk Lymphoma; 2003 Apr; 44(4):627-33. PubMed ID: 12769339
[TBL] [Abstract][Full Text] [Related]
7. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
8. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
[TBL] [Abstract][Full Text] [Related]
9. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
[TBL] [Abstract][Full Text] [Related]
10. Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas.
Benesch M; Lackner H; Moser A; Kerbl R; Schwinger W; Oberbauer R; Eder HG; Mayer R; Wiegele K; Urban C
Pediatr Neurosurg; 2001 Oct; 35(4):173-80. PubMed ID: 11694794
[TBL] [Abstract][Full Text] [Related]
11. Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model.
Fortin D; McCormick CI; Remsen LG; Nixon R; Neuwelt EA
Neurosurgery; 2000 Jul; 47(1):199-207. PubMed ID: 10917363
[TBL] [Abstract][Full Text] [Related]
12. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
[TBL] [Abstract][Full Text] [Related]
13. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
[TBL] [Abstract][Full Text] [Related]
14. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
[TBL] [Abstract][Full Text] [Related]
15. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
Jennings MT; Sposto R; Boyett JM; Vezina LG; Holmes E; Berger MS; Bruggers CS; Bruner JM; Chan KW; Dusenbery KE; Ettinger LJ; Fitz CR; Lafond D; Mandelbaum DE; Massey V; McGuire W; McNeely L; Moulton T; Pollack IF; Shen V
J Clin Oncol; 2002 Aug; 20(16):3431-7. PubMed ID: 12177103
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.
Bouffet E; Raquin M; Doz F; Gentet JC; Rodary C; Demeocq F; Chastagner P; Lutz P; Hartmann O; Kalifa C
Cancer; 2000 Feb; 88(3):685-92. PubMed ID: 10649264
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
Ohno M; Natsume A; Fujii M; Ito M; Wakabayashi T
Pediatr Blood Cancer; 2009 Jul; 53(1):37-41. PubMed ID: 19260101
[TBL] [Abstract][Full Text] [Related]
18. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
[TBL] [Abstract][Full Text] [Related]
19. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
[TBL] [Abstract][Full Text] [Related]
20. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
